← Back to Search

PhoRTE + EMST for Voice Disorders

N/A

Waitlist Available

Led By Amanda Gillespie

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at each study visit through study completion; time 0 (therapy visit 1-baseline), follow-up week 1 (therapy visit 2), follow-up week 2 (therapy visit 3),follow-up week 3 (therapy visit 4), follow-up week 5 (follow up visit)

Awards & highlights

No Placebo-Only Group

Summary

The larynx and vocal folds undergo many age-related changes in their physiology and structure that can lead to undesirable effects on the voice, with changes in the respiratory system compounding these deficits. These changes, also called presbyphonia, can have serious detrimental effects on the lives of elderly individuals. There are few studies that have evaluated the use of voice therapy treatment options for these patients. The primary aim of this study is to test whether the addition of expiratory muscle strength training (EMST) to a current, validated voice therapy protocol aimed at treating presbyphonia, (phonation resistance training, PhoRTE) can improve outcomes of therapy.

Eligible Conditions

Voice Disorders
Vocal Cord Atrophy
Age-Related Voice Change

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at each study visit through study completion; time 0 (therapy visit 1-baseline), follow-up week 1 (therapy visit 2), follow-up week 2 (therapy visit 3),follow-up week 3 (therapy visit 4), follow-up week 5 (follow up visit)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at each study visit through study completion; time 0 (therapy visit 1-baseline), follow-up week 1 (therapy visit 2), follow-up week 2 (therapy visit 3),follow-up week 3 (therapy visit 4), follow-up week 5 (follow up visit)

This trial's timeline: 3 weeks for screening, Varies for treatment, and at each study visit through study completion; time 0 (therapy visit 1-baseline), follow-up week 1 (therapy visit 2), follow-up week 2 (therapy visit 3),follow-up week 3 (therapy visit 4), follow-up week 5 (follow up visit) for reporting.